Health Care & Life Sciences » Biotechnology | Kang Stem Biotech Co. Ltd.

Kang Stem Biotech Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
6,633
3,030
17,885
36,395
19,092
Total Accounts Receivable
9
149
481
617
761
Inventories
12
224
335
583
1,841
Other Current Assets
734
416
196
371
3,669
Total Current Assets
7,388
3,818
18,897
37,966
25,363
Net Property, Plant & Equipment
2,874
2,628
2,980
4,039
13,215
Total Investments and Advances
67
48
1,688
661
4,122
Long-Term Note Receivable
-
-
-
3,344
192
Intangible Assets
694
767
854
951
4,183
Other Assets
-
-
564
480
326
Total Assets
11,022
7,261
24,983
47,442
47,401
ST Debt & Current Portion LT Debt
1,774
2,289
288
260
1,910
Accounts Payable
-
307
125
276
1,240
Other Current Liabilities
972
722
2,553
2,695
3,186
Total Current Liabilities
2,746
3,318
2,966
3,231
6,335
Long-Term Debt
4,925
5,397
780
15,286
12,341
Provision for Risks & Charges
313
459
-
-
509
Other Liabilities
1,263
-
-
5,948
3,499
Total Liabilities
9,246
9,174
3,746
24,465
22,684
Common Equity (Total)
1,777
1,913
21,237
22,977
25,462
Total Shareholders' Equity
1,777
1,913
21,237
22,977
25,462
Total Equity
1,777
1,913
21,237
22,977
24,717
Liabilities & Shareholders' Equity
11,022
7,261
24,983
47,442
47,401
Accumulated Minority Interest
-
-
-
-
745

About Kang Stem Biotech Co.

View Profile
Address
17th Floor, Shinan Building
Seoul SL 06179
Korea, Republic Of
Employees -
Website http://www.kangstem.com
Updated 09/14/2018
KangStem Biotech Co., Ltd. develops and commercializes stem cell therapies. Its therapies include next generation and gene-loaded stem cell. In addition, it also provides contract research and manufacturing services and drug screening services.